Blood levels of sulfadoxine and pyrimethamine, according to the malaria-treatment response, in two municipalities of Antioquia, Colombia;Concentraciones sanguíneas de sulfadoxina y pirimetamina según la respuesta terapéutica antimalárica, en dos municipios de Antioquia, Colombia

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 18, Issue 2, 2005, Pages 75-83

  Carmona, Jaime ^a   Pabón, Adriana ^a   Márquez, Diana ^a   López, Carlos ^a   Morales, Gladys ^b   Blair, Silvia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD DE MEDELLÍN   (Colombia)

Author keywords

Antimalarials; Chromatography, high pressure liquid; Malaria, falciparum; Pyrimethamine; Sulfadoxine

Indexed keywords

PYRIMETHAMINE; SULFADOXINE;

DISEASE TREATMENT; DRUG PRESCRIBING; MALARIA;

ADOLESCENT; ADULT; ARTICLE; CHILD; COLOMBIA; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; EVALUATION; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM FALCIPARUM; QUANTITATIVE DIAGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

ANTIOQUIA; COLOMBIA; SOUTH AMERICA; WESTERN HEMISPHERE; WORLD;

PLASMODIUM FALCIPARUM;

EID: 24344480458     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892005000700001     Document Type: Article

References (37)

1. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of protozoal infections. En: Hardman JG, Limbird LE, eds. Goodman & Gilman. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001. Pp. 1080-2.
2. Mandell G, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett. Principles and Practice of Infectious Diseases. 5th ed. Vol 1. Philadelphia: Churchill Livingstone; 2000.
3. Petri WA Jr. Antimicrobial agents. Sulfonamides, trimetoprim- sulfamethoxazole, quinolones and agents for urinary infections. En: Hardman JG, Limbird LE, eds. Goodman & Gilman. The Pharmacological Basis of Therapeutics, 10a ed. New York: McGraw-Hill; 2001;1171-6.
4. Heizmann P, Fernex M, Leimer R, Reber-Liske R, Stohler H. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine. Lancet. 1986;1(8477):377.
5. Malin AS, Hall AP. Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine. Br Med J. 1990;300(6733):1175.
6. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996;90(2):179-81.
7. Onyiorah E, van Hensbroek MB, Jah MS, Greenwood B. Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 1990;90(3):307-8.
8. Sowunmi A, Oduola AM, Ogundahunsi OA, Salako LA. Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg. 1998;92(1): 77-81.
9. Van Dillen J, Custers M, Wensink A, Wouters B, van Voorthuizen T, Voorn W, et al. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya: 1. Trans R Soc Trop Med Hyg. 1999;93(2):185-8.
10. Deloron P, Mayombo J, Le Cardinal A, Mezui-Me-Ndong J, Bruzi-Baert C, Lekoulou F, Elissa N. Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children. Trans R Soc Trop Med Hyg. 2000;94(2):188-90.
11. Nwanyanwu OC, Ziba C, MacHeso A, Kazembe P. Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old. Trop Med Int Health. 2000;5(5):355-8.
12. Von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000;355(9201):352-7.
13. Erratum in: Lancet. 2000;355(9220):2080.
14. Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, et al. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet. 2001; 358(9279):368-74.
15. Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. Am J Trop Med Hyg. 2001;65(4):309-17.
16. Blair S, Lacharme L, Carmona J, Tobón A. Resistencia del Plasmodium falciparum a los antimaláricos en Urabá y Bajo Cauca Antioqueño, 1998. Rev Epidemiol Antioquia. 1999;24(3-4): 207-15.
17. Blair S. Resistencia a los antimaláricos. En: Carmona-Fonseca J. Tópicos de infectología. Medellín: Universidad de Antioquia, 1999; 81-91.
18. Blair S, Lacharme-Lora L, Carmona-Fonseca J. Resistance of Plasmodium falciparum to antimalarial drugs in Zaragoza (Antioquia, Colombia), 1998. Mem Inst Oswaldo Cruz. (Rio de Janeiro) 2002;97(3):401-6.
19. Blair S, Lacharme L, Carmona J, Tobón A. Resistencia del Plasmodium falciparum a tres fármacos antimaláricos en Turbo (Antioquia, Colombia), 1998. Rev Panam Salud Publica. 2001;9(1):23-9.
20. Espinal CA, Uribe LM, Eslava A, Rodríguez ME. Resistencia del P. falciparum a la combinación sulfadoxina-pirimetamina. Description de los primeros tres casos en Colombia. Biomedica. 1981;1(4):213-7.
21. Botero D, Restrepo M, Montoya A. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of P. falciparum malaria. Bull World Health Organ. 1985;63:731-7.
22. Soto J, Martínez R, Fonschiffrey G, Dember J. Efficacy of Fansidar for acute uncomplicated malaria due to Plasmodium falciparum in Colombia. Trans R Soc Trop Med Hyg. 1995; 89(3):306.
23. Blair S. Resistencia de P. falciparum a drogas en Colombia. Biomédica. 1986;6(3-4):95-100.
24. Osorio LE, Giraldo LE, Grajales LF, Arriaga AL, Andrade AL, Ruebush TK 2nd, et al. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia. Am J Trop Med Hyg. 1999;61(6):968-72.
25. Osorio LE, Giraldo LE, Grajales LF, Barat LM, Córdoba F, Arriaga AL, et al. Evaluación in vivo de la resistencia de Plasmodium falciparum a cloroquina y sulfa/pirimetamina en Quibdó, Chocó. Biomedica. 1997; 17(supl. 2): 201-2.
26. Lopez YL, Arroyabe A, Salazar A. Evaluación de la resistencia in vivo a los medicamentos antimaláricos. El Bagre, Antioquia, 1998. Rev Epidemiol Antioquia. 1999;24(3-4):181-94.
27. Ministerio de Salud de Colombia, Dirección General de Salud Pública, Grupo de Vigilancia en Salud Pública. Casos y tasa de incidencia de malaria por municipio según especie. Santa Fe de Bogotá: Minsalud; 2001.
28. Sierra ML, Vélez LM, Castañeda AM, Galeano LA, Molina AL, Tabares Z, et al. Diagnóstico de la situación de salud en Antioquia. Rev Epidemiol Antioquia. 2000;25(1-3):129-32.
29. López-Antuñano FJ, Schmunis G, eds. Diagnõstico de malaria. Washington, D.C.: Organización Panamericana de la Salud, 1988. (Publicación Científica 512).
30. Organización Panamericana de la Salud. Evaluación de la eficacia terapéutica de los medicamentos para el tratamiento del paludismo por Plasmodium falciparum sin complicaciones en las Américas. Washington, D.C.: OPS; 1998. (Documento OPS/HCP/HCT/113/98).
31. Colombia, Ministerio de Salud. Guía de atención clínica para el diagnóstico y tratamiento de la malaria. Santa Fe de Bogotá; Minsalud; 1999.
32. Green M, Mount D, Netty H. High-perfomance liquid cromatographic assay for the simultaneous determination of sulfadoxine and pyrimethamine from whole blood dried onto filter paper. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;767(1): 159-62
33. Weidekamm E, Plozza-Nottebrock H, Forgo I, Dubach UC. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bull World Health Organ. 1982;60(1): 115-22.
34. Lell B, Lehman LG, Schmidt-Ott JR, Sturchler D, Handschin J, Kremsner PG. Malaria chemotherapy trial at a minimal effective dose of mefloquine/ sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/ pyrimethamine or mefloquine alone. Am J Trop Med Hyg. 1998; 58(5):619-24.
35. Hellgren U, Kihamia CM, Bergqvist Y, Lebbad M, Premji Z, Rombo L. Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Trans R Soc Trop Med Hyg. 1990;84(4):469-72.
36. Kun JF, Lehman LG, Lell B, Schmidt-Ott R, Kremsner PG. Low-dose treatment with sulfadoxine/pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 1999;43(9):2205-8.
37. Spencer HC, Watkins WW, Sixsmith DG, Koech DK. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya. Trans R Soc Trop Med Hyg. 1986;80(2):201-13.